All In MedTech

Company

Apollo Endosurgery

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.

Private

Total raised (reported)

$160M

7 Form D offerings, 2009 to 2020

Equity

$132M

Stock sold for cash

Debt and convertible notes

$28.0M

$25.0M of it convertible

Last known valuation

Unknown

Form D filings do not report valuation

Latest round: equity, $25.0M raised of $25.0M sought, first sale Jul 21, 2020, 18 investors.

Funding rounds (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Jul 21, 2020Equity$25.0M$25.0M18Rule 506(b)Agent: Craig-Hallum Capital Group LLCCommissions $1.6MForm D ↗Jul 30, 2020
Aug 12, 2019Convertible note$20.0M$20.0M18Rule 506(b)Agent: Craig-Hallum Capital Group LLCCommissions $1.3MForm D ↗Aug 27, 2019
Dec 29, 2016Equity$54.4M$54.4M15Rule 506(b)Form D ↗Jan 11, 2017

4 more funding rounds with a free account

Company details

From the company's latest Form D.

Legal name
Apollo Endosurgery, Inc.; APOLLO ENDOSURGERY US INC
Headquarters
Austin, Texas
Incorporated
Delaware over five years before filing
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Biotechnology

Executives, directors and promoters

As listed on the latest Form D.

    12 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    No 5%+ shareholder filings or SBIR grants found under the name Apollo Endosurgery.

    Latest FDA decisions

    Search the Clearance Tracker

    5 more FDA decisions with a free account

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar

    3 more trials with a free account

    Reports received

    179

    Received Nov 1, 2025 to Nov 20, 2026

    Malfunction reports

    110

    61% of reports

    Injury reports

    69

    39% of reports

    Death reports

    0

    0.0% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 23121300
    Jan 24111700
    Feb 2412400
    Mar 2419300
    Apr 2413410
    May 2410510
    Jun 2441010
    Jul 246300
    Aug 2421900
    Sep 244800
    Oct 2412810
    Nov 242400
    Dec 2431200
    Jan 2512900
    Feb 2581200
    Mar 25111400
    Apr 255300
    May 257400
    Jun 259300
    Jul 25151000
    Aug 258700
    Sep 255500
    Oct 259520
    Nov 2513900
    Dec 2519700
    Jan 2611600
    Feb 26181000
    Mar 266100
    Apr 263600
    May 265400
    Jun 262200
    Jul 2615600
    Aug 264300
    Sep 2611500
    Oct 2631000
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    7 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.